Multiple donor-derived leukemias in a recipient of allogeneic hematopoietic cell transplantation for myeloid malignancy
Authors:
- 6 October 2020
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (19) , 4798-4801
Abstract
Key Points: A patient with myelodysplastic syndrome was transplanted twice and developed clonally unrelated relapse each time in donor-derived cells. This case supports the concept that a leukemogenic marrow environment may predispose the transplant recipient to malignant transformation.Keywords
This publication has 17 references indexed in Scilit:
- European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantationLeukemia, 2018
- The interplay of leukemia cells and the bone marrow microenvironmentBlood, 2018
- Donor-derived myeloid neoplasm post allogeneic hematopoietic cell transplantationBlood, 2017
- Donor Cell Leukemia: A ReviewTransplantation and Cellular Therapy, 2011
- Donor Cell–Derived Leukemias/Myelodysplastic Neoplasms in Allogeneic Hematopoietic Stem Cell Transplant RecipientsAmerican Journal of Clinical Pathology, 2011
- Donor cell leukemia: insight into cancer stem cells and the stem cell nicheBlood, 2006
- Evidence of Donor-Derived Hematologic Malignancies after Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2006
- Donor cell leukemia after non-myeloablative allogeneic stem cell transplantation: A single institution experienceLeukemia & Lymphoma, 2006
- First report of donor cell–derived acute leukemia as a complication of umbilical cord blood transplantationBlood, 2005
- Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphomaAmerican Journal of Hematology, 2005